. Author manuscript; available in PMC: 2009 Aug 20.

Published in final edited form as: Int J Biochem Cell Biol. 2007 Oct 23;40(4):565–575. doi: 10.1016/j.biocel.2007.10.018

Table 1.

list of HDACi used in clinical trials (*SAHA has been approved for clinical trials).

Chemical classification	Commercial names of the compounds
Aliphatic acids	Valproic acid
	Phenylbutyrrate
	Savicol
	AN-9
	Baceca
Hydroxamate	LBH589
	ITF2357
	FK228
	PXD101
	PCI24781
	SAHA, or Zolinza, or vorinostat*
Benzamide	MGCD0103
	MS-275
Cyclic tetrapeptide	Depsipeptide